A second variant translocation, t(9; 17)(q22; q11), has been detected in approximately 15% of EMC and results in a TAF15-NR4A3 fusion gene [78–82]. The gene discussed is NR4A3; the disease is extraskeletal myxoid chondrosarcoma.